NewsForce(@Newsforce):🇯🇵🇬🇧 Three drug companies are teaming up to test whether two cancer drugs work better together. AstraZeneca and Daiichi Sankyo will pair their drug Datroway with Summit Therapeutics' ivonescimab in several cancers, including lung and breast. They'll start with a Phase III trial in triple-negative breast cancer as a first treatment. Each company supplies its own drug, shares trial costs, and keeps its own rights. The deal builds on AstraZeneca's $2 billion investment in Summit.

2026.10.02 10:15

🇯🇵🇬🇧 Three drug companies are teaming up to test whether two cancer drugs work better together. AstraZeneca and Daiichi Sankyo will pair their drug Datroway with Summit Therapeutics' ivonescimab in several cancers, including lung and breast. They'll start with a Phase III trial in triple-negative breast cancer as a first treatment. Each company supplies its own drug, shares trial costs, and keeps its own rights. The deal builds on AstraZeneca's $2 billion investment in Summit.

显示更多